363 related articles for article (PubMed ID: 36138229)
1. Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation.
Nam AS; Dusaj N; Izzo F; Murali R; Myers RM; Mouhieddine TH; Sotelo J; Benbarche S; Waarts M; Gaiti F; Tahri S; Levine R; Abdel-Wahab O; Godley LA; Chaligne R; Ghobrial I; Landau DA
Nat Genet; 2022 Oct; 54(10):1514-1526. PubMed ID: 36138229
[TBL] [Abstract][Full Text] [Related]
2. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response.
Scheller M; Ludwig AK; Göllner S; Rohde C; Krämer S; Stäble S; Janssen M; Müller JA; He L; Bäumer N; Arnold C; Gerß J; Schönung M; Thiede C; Niederwieser C; Niederwieser D; Serve H; Berdel WE; Thiem U; Hemmerling I; Leuschner F; Plass C; Schlesner M; Zaugg J; Milsom MD; Trumpp A; Pabst C; Lipka DB; Müller-Tidow C
Nat Cancer; 2021 May; 2(5):527-544. PubMed ID: 35122024
[TBL] [Abstract][Full Text] [Related]
3. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.
Guryanova OA; Shank K; Spitzer B; Luciani L; Koche RP; Garrett-Bakelman FE; Ganzel C; Durham BH; Mohanty A; Hoermann G; Rivera SA; Chramiec AG; Pronier E; Bastian L; Keller MD; Tovbin D; Loizou E; Weinstein AR; Gonzalez AR; Lieu YK; Rowe JM; Pastore F; McKenney AS; Krivtsov AV; Sperr WR; Cross JR; Mason CE; Tallman MS; Arcila ME; Abdel-Wahab O; Armstrong SA; Kubicek S; Staber PB; Gönen M; Paietta EM; Melnick AM; Nimer SD; Mukherjee S; Levine RL
Nat Med; 2016 Dec; 22(12):1488-1495. PubMed ID: 27841873
[TBL] [Abstract][Full Text] [Related]
4. DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts.
Shumliakivska M; Luxán G; Hemmerling I; Scheller M; Li X; Müller-Tidow C; Schuhmacher B; Sun Z; Dendorfer A; Debes A; Glaser SF; Muhly-Reinholz M; Kirschbaum K; Hoffmann J; Nagel E; Puntmann VO; Cremer S; Leuschner F; Abplanalp WT; John D; Zeiher AM; Dimmeler S
Nat Commun; 2024 Jan; 15(1):606. PubMed ID: 38242884
[TBL] [Abstract][Full Text] [Related]
5. [Functional role of DNMT3A mutation in acute myeloid leukemia].
Koya J; Kurokawa M
Rinsho Ketsueki; 2018; 59(5):602-610. PubMed ID: 29877252
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders.
Midic D; Rinke J; Perner F; Müller V; Hinze A; Pester F; Landschulze J; Ernst J; Gruhn B; Matziolis G; Heidel FH; Hochhaus A; Ernst T
Leukemia; 2020 Aug; 34(8):2198-2205. PubMed ID: 32457355
[TBL] [Abstract][Full Text] [Related]
7. Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21.
Zhang CR; Ostrander EL; Kukhar O; Mallaney C; Sun J; Haussler E; Celik H; Koh WK; King KY; Gontarz P; Challen GA
Blood Cancer Discov; 2022 May; 3(3):220-239. PubMed ID: 35394496
[TBL] [Abstract][Full Text] [Related]
8. Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis.
Carrà G; Giugliano E; Camerlo S; Rosati G; Branca E; Maffeo B; Russo I; Piazza R; Cilloni D; Morotti A
Haematologica; 2023 May; 108(5):1447-1449. PubMed ID: 36226499
[No Abstract] [Full Text] [Related]
9. Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Chen Q; Qian W; Li Y; Yang J; Wang CZ; Chai HY; Qian Z; Xiao GF; Xu WR
PLoS One; 2011; 6(10):e26906. PubMed ID: 22066015
[TBL] [Abstract][Full Text] [Related]
10. Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion.
Tovy A; Reyes JM; Gundry MC; Brunetti L; Lee-Six H; Petljak M; Park HJ; Guzman AG; Rosas C; Jeffries AR; Baple E; Mill J; Crosby AH; Sency V; Xin B; Machado HE; Castillo D; Weitzel JN; Li W; Stratton MR; Campbell PJ; Wang H; Sanders MA; Goodell MA
Cell Stem Cell; 2020 Aug; 27(2):326-335.e4. PubMed ID: 32673568
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous Dnmt3a R878C induces expansion of quiescent hematopoietic stem cell pool.
Higo T; Suzuki Y; Sato M; Koya J; Mizuno H; Miyauchi M; Masamoto Y; Kataoka K; Sumitomo Y; Tsuruta-Kishino T; Sato T; Kurokawa M
Exp Hematol; 2022 May; 109():45-54. PubMed ID: 35245608
[TBL] [Abstract][Full Text] [Related]
12. Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.
Abplanalp WT; Cremer S; John D; Hoffmann J; Schuhmacher B; Merten M; Rieger MA; Vasa-Nicotera M; Zeiher AM; Dimmeler S
Circ Res; 2021 Jan; 128(2):216-228. PubMed ID: 33155517
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis.
Zioni N; Bercovich AA; Chapal-Ilani N; Bacharach T; Rappoport N; Solomon A; Avraham R; Kopitman E; Porat Z; Sacma M; Hartmut G; Scheller M; Muller-Tidow C; Lipka D; Shlush E; Minden M; Kaushansky N; Shlush LI
Nat Commun; 2023 Apr; 14(1):2070. PubMed ID: 37045808
[TBL] [Abstract][Full Text] [Related]
14. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling.
Hormaechea-Agulla D; Matatall KA; Le DT; Kain B; Long X; Kus P; Jaksik R; Challen GA; Kimmel M; King KY
Cell Stem Cell; 2021 Aug; 28(8):1428-1442.e6. PubMed ID: 33743191
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation disruption reshapes the hematopoietic differentiation landscape.
Izzo F; Lee SC; Poran A; Chaligne R; Gaiti F; Gross B; Murali RR; Deochand SD; Ang C; Jones PW; Nam AS; Kim KT; Kothen-Hill S; Schulman RC; Ki M; Lhoumaud P; Skok JA; Viny AD; Levine RL; Kenigsberg E; Abdel-Wahab O; Landau DA
Nat Genet; 2020 Apr; 52(4):378-387. PubMed ID: 32203468
[TBL] [Abstract][Full Text] [Related]
17. Identification of three novel DNMT3A mutations with compromising methylation capacity in human acute myeloid leukaemia.
Ali AM; Salih GF
Mol Biol Rep; 2022 Dec; 49(12):11685-11693. PubMed ID: 36175738
[TBL] [Abstract][Full Text] [Related]
18. A Model System for Studying the DNMT3A Hotspot Mutation (DNMT3A
Lu R; Wang J; Ren Z; Yin J; Wang Y; Cai L; Wang GG
Cancer Res; 2019 Jul; 79(14):3583-3594. PubMed ID: 31164355
[TBL] [Abstract][Full Text] [Related]
19. Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.
Tovy A; Rosas C; Gaikwad AS; Medrano G; Zhang L; Reyes JM; Huang YH; Arakawa T; Kurtz K; Conneely SE; Guzman AG; Aguilar R; Gao A; Chen CW; Kim JJ; Carter MT; Lasa-Aranzasti A; Valenzuela I; Van Maldergem L; Brunetti L; Hicks MJ; Marcogliese AN; Goodell MA; Rau RE
Haematologica; 2022 Apr; 107(4):887-898. PubMed ID: 34092059
[TBL] [Abstract][Full Text] [Related]
20. Oridonin inhibits DNMT3A R882 mutation-driven clonal hematopoiesis and leukemia by inducing apoptosis and necroptosis.
Liao M; Dong Q; Chen R; Xu L; Jiang Y; Guo Z; Xiao M; He W; Cao C; Hu R; Sun W; Jiang H; Wang J
Cell Death Discov; 2021 Oct; 7(1):297. PubMed ID: 34663800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
